214 related articles for article (PubMed ID: 15269480)
1. Role of magnetic resonance perfusion studies in moyamoya disease.
Khanna PC; Lath C; Gadewar SB; Patkar DP
Neurol India; 2004 Jun; 52(2):238-40. PubMed ID: 15269480
[TBL] [Abstract][Full Text] [Related]
2. Moyamoya disease--magnetic resonance imaging and magnetic resonance angiographic features.
Gupta R; Kumari R; Gupta N; Prakash A; Chowdhury V
J Indian Med Assoc; 2006 Apr; 104(4):198-9. PubMed ID: 16910328
[TBL] [Abstract][Full Text] [Related]
3. Focal time-to-peak changes on perfusion MRI in children with Moyamoya disease: correlation with conventional angiography.
Choi HS; Kim DS; Shim KW; Kim J; Kim ES; Lee SK
Acta Radiol; 2011 Jul; 52(6):675-9. PubMed ID: 21525108
[TBL] [Abstract][Full Text] [Related]
4. Perfusion-weighted magnetic resonance imaging in adult moyamoya syndrome: characteristic patterns and change after surgical intervention: case report.
Wityk RJ; Hillis A; Beauchamp N; Barker PB; Rigamonti D
Neurosurgery; 2002 Dec; 51(6):1499-505; discussion 1506. PubMed ID: 12445358
[TBL] [Abstract][Full Text] [Related]
5. CT perfusion imaging for childhood moyamoya disease before and after surgical revascularization.
Sakamoto S; Ohba S; Shibukawa M; Kiura Y; Arita K; Kurisu K
Acta Neurochir (Wien); 2006 Jan; 148(1):77-81; discussion 81. PubMed ID: 16184319
[TBL] [Abstract][Full Text] [Related]
6. [A case of moyamoya disease diagnosed by cerebral ischemic symptoms induced by anti-hypertensive therapy].
Yanagawa Y; Ogura M; Okuda E; Okunaga T; Takahata H; Nakamura M
No Shinkei Geka; 2003 Mar; 31(3):275-9. PubMed ID: 12684981
[TBL] [Abstract][Full Text] [Related]
7. Surgical treatment of moyamoya syndrome in patients with sickle cell anemia: outcome following encephaloduroarteriosynangiosis.
Hankinson TC; Bohman LE; Heyer G; Licursi M; Ghatan S; Feldstein NA; Anderson RC
J Neurosurg Pediatr; 2008 Mar; 1(3):211-6. PubMed ID: 18352765
[TBL] [Abstract][Full Text] [Related]
8. [Clinical features and outcomes of 10 asymptomatic adult patients with moyamoya disease].
Nanba R; Kuroda S; Takeda M; Shichinohe H; Nakayama N; Ishikawa T; Houkin K; Iwasaki Y
No Shinkei Geka; 2003 Dec; 31(12):1291-5. PubMed ID: 14719442
[TBL] [Abstract][Full Text] [Related]
9. Moyamoya disease in children.
Takanashi J
Brain Dev; 2011 Mar; 33(3):229-34. PubMed ID: 20932697
[TBL] [Abstract][Full Text] [Related]
10. Moyamoya disease associated with hereditary spherocytosis.
Vo Van P; Sabouraud P; Mac G; Abely M; Bednarek N
Pediatr Neurol; 2011 Jan; 44(1):69-71. PubMed ID: 21147392
[TBL] [Abstract][Full Text] [Related]
11. Moyamoya syndrome with protein S deficiency.
Akgün D; YiLmaz S; Senbil N; Aslan B; Gürer YY
Eur J Paediatr Neurol; 2000; 4(4):185-8. PubMed ID: 11008263
[TBL] [Abstract][Full Text] [Related]
12. [Repeated, reversible MR angiographic findings in pediatric moyamoya disease: case report].
Osanai T; Kuroda S; Ishikawa T; Kudo K; Terae S; Isobe M; Iwasaki Y
No Shinkei Geka; 2006 Apr; 34(4):403-7. PubMed ID: 16613222
[TBL] [Abstract][Full Text] [Related]
13. Clinical significance of posterior circulation changes after revascularization in patients with moyamoya disease.
Huang AP; Liu HM; Lai DM; Yang CC; Tsai YH; Wang KC; Yang SH; Kuo MF; Tu YK
Cerebrovasc Dis; 2009; 28(3):247-57. PubMed ID: 19602876
[TBL] [Abstract][Full Text] [Related]
14. Quantitative evaluation of cerebral hemodynamics in patients with moyamoya disease by dynamic susceptibility contrast magnetic resonance imaging--comparison with positron emission tomography.
Tanaka Y; Nariai T; Nagaoka T; Akimoto H; Ishiwata K; Ishii K; Matsushima Y; Ohno K
J Cereb Blood Flow Metab; 2006 Feb; 26(2):291-300. PubMed ID: 16049427
[TBL] [Abstract][Full Text] [Related]
15. Childhood moyamoya disease: quantitative evaluation of perfusion MR imaging--correlation with clinical outcome after revascularization surgery.
Yun TJ; Cheon JE; Na DG; Kim WS; Kim IO; Chang KH; Yeon KM; Song IC; Wang KC
Radiology; 2009 Apr; 251(1):216-23. PubMed ID: 19332853
[TBL] [Abstract][Full Text] [Related]
16. [Clinical manifestations of infantile moyamoya disease].
Kuroda S; Nanba R; Ishikawa T; Houkin K; Kamiyama H; Iwasaki Y
No Shinkei Geka; 2003 Oct; 31(10):1073-8. PubMed ID: 14598644
[TBL] [Abstract][Full Text] [Related]
17. Leptomeningeal enhancement in petients with moyamoya disease: correlation with perfusion imaging.
Chung PW; Park KY
Neurology; 2009 May; 72(21):1872-3. PubMed ID: 19470971
[No Abstract] [Full Text] [Related]
18. Diagnosis of moyamoya disease on magnetic resonance imaging: are flow voids in the basal ganglia an essential criterion for definitive diagnosis?
Mikami T; Sugino T; Ohtaki S; Houkin K; Mikuni N
J Stroke Cerebrovasc Dis; 2013 Aug; 22(6):862-8. PubMed ID: 22939199
[TBL] [Abstract][Full Text] [Related]
19. Presumed perinatal stroke in a child with Down syndrome and moyamoya disease.
Pysden K; Fallon P; Moorthy B; Ganesan V
Dev Med Child Neurol; 2010 Feb; 52(2):212-4. PubMed ID: 19583743
[TBL] [Abstract][Full Text] [Related]
20. [Usefulness and limitation of MR imaging and MR angiography in diagnosis of juvenile moyamoya disease].
Aoki T; Matsuzawa H; Houkin K; Kamiyama H; Abe H; Miyasaka K; Saito H
No Shinkei Geka; 1993 Apr; 21(4):305-11. PubMed ID: 8474584
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]